Key result
Performance-based risk-sharing arrangements in cardiac electrophysiology link reimbursement to clinical outcomes, requiring physician engagement in technology assessment and patient outcome evaluation.
Why the study?
Increasing pressure to demonstrate the value of costly medical technologies has led to novel performance-based risk-sharing arrangements, requiring cardiac electrophysiology physicians to prepare for stakeholder involvement.
Physicians and scientific associations in electrophysiology must prepare to engage as stakeholders in performance-based risk-sharing agreements to assess the value and outcomes of innovative technologies.
Answers are grounded in this paper and cite their sources.
EP clinicians and societies should prepare for risk-sharing agreements; leaves open their impact on innovation value and costs.
There is an increasing pressure on demonstrating the value of medical interventions and medical technologies resulting in the proposal of new approaches for implementation in the daily practice of innovative treatments that might carry a substantial cost. While originally mainly adopted by pharmaceutical companies, in recent years medical technology companies have initiated novel value-based arrangements for using medical devices, in the form of 'outcomes-based contracts', 'performance-based contracts', or 'risk-sharing agreements'. These are all characterized by linking coverage, reimbursement, or payment for the innovative treatment to the attainment of pre-specified clinical outcomes. Risk-sharing agreements have been promoted also in the field of electrophysiology and offer the possibility to demonstrate the value of specific innovative technologies proposed in this rapidly advancing field, while relieving hospitals from taking on the whole financial risk themselves. Physicians deeply involved in the field of devices and technologies for arrhythmia management and invasive electrophysiology need to be prepared for involvement as stakeholders. This may imply engagement in the evaluation of risk-sharing agreements and specifically, in the process of assessment of technology performances or patient outcomes. Scientific Associations may have an important role in promoting the basis for value-based assessments, in promoting educational initiatives to help assess the determinants of the learning curve for innovative treatments, and in promoting large-scale registries for a precise assessment of patient outcomes and of specific technologies' performance.
No takes yet. Share an insight, caveat, or question.
Boriani et al. (2022) conducted a review in Cardiac electrophysiology and arrhythmia management. Performance-based risk-sharing arrangements was evaluated. Performance-based risk-sharing arrangements in cardiac electrophysiology link reimbursement to clinical outcomes, requiring physician engagement in technology assessment and patient outcome evaluation.
Synapse has enriched 10 related papers. Consider them for comparative context: